The Heptaprenyl Diphosphate Synthase (Coq1) Is the Target of a Lipophilic Bisphosphonate That Protects Mice against Toxoplasma gondii Infection.
The Heptaprenyl Diphosphate Synthase (Coq1) Is the Target of a Lipophilic Bisphosphonate That Protects Mice against Toxoplasma gondii Infection.
复制标题
DOI:
10.1128/mbio.01966-22
复制
发表时间:
2022-10-26
期刊:
影响因子:
6.4
通讯作者:
Moreno, Silvia N. J.
中科院分区:
文献类型:
--
作者:
Sleda, Melissa A.;Li, Zhu-Hong;Behera, Ranjan;Baierna, Baihetiya;Li, Catherine;Jumpathong, Jomkwan;Malwal, Satish R.;Kawamukai, Makoto;Oldfield, Eric;Moreno, Silvia N. J.
Prenyldiphosphate synthases catalyze the reaction of allylic diphosphates with one or more isopentenyl diphosphate molecules to form compounds such as farnesyl diphosphate, used in, e.g., sterol biosynthesis and protein prenylation, as well as longer “polyprenyl” diphosphates, used in ubiquinone and menaquinone biosynthesis. Quinones play an essential role in electron transport and are associated with the inner mitochondrial membrane due to the presence of the polyprenyl group. In this work, we investigated the synthesis of the polyprenyl diphosphate that alkylates the ubiquinone ring precursor in Toxoplasma gondii, an opportunistic pathogen that causes serious disease in immunocompromised patients and the unborn fetus. The enzyme that catalyzes this early step of the ubiquinone synthesis is Coq1 (TgCoq1), and we show that it produces the C35 species heptaprenyl diphosphate. TgCoq1 localizes to the mitochondrion and is essential for in vitro T. gondii growth. We demonstrate that the growth defect of a T. gondii TgCoq1 mutant is rescued by complementation with a homologous TgCoq1 gene or with a (C45) solanesyl diphosphate synthase from Trypanosoma cruzi (TcSPPS). We find that a lipophilic bisphosphonate (BPH-1218) inhibits T. gondii growth at low-nanomolar concentrations, while overexpression of the TgCoq1 enzyme dramatically reduced growth inhibition by the bisphosphonate. Both the severe growth defect of the mutant and the inhibition by BPH-1218 were rescued by supplementation with a long-chain (C30) ubiquinone (UQ6). Importantly, BPH-1218 also protected mice against a lethal T. gondii infection. TgCoq1 thus represents a potential drug target that could be exploited for improved chemotherapy of toxoplasmosis.
登录
查看更多内容
DOI:
10.1093/bioinformatics/8.3.275
发表时间:
1992-06-01
期刊:
COMPUTER APPLICATIONS IN THE BIOSCIENCES
影响因子:
--
作者:
JONES, DT;TAYLOR, WR;THORNTON, JM
通讯作者:
THORNTON, JM
DOI:
10.2147/dddt.s60973
发表时间:
2017
期刊:
Drug design, development and therapy
影响因子:
--
作者:
Alday PH;Doggett JS
通讯作者:
Doggett JS
影响因子:
64.8
作者:
Jumper J;Evans R;Pritzel A;Green T;Figurnov M;Ronneberger O;Tunyasuvunakool K;Bates R;Žídek A;Potapenko A;Bridgland A;Meyer C;Kohl SAA;Ballard AJ;Cowie A;Romera-Paredes B;Nikolov S;Jain R;Adler J;Back T;Petersen S;Reiman D;Clancy E;Zielinski M;Steinegger M;Pacholska M;Berghammer T;Bodenstein S;Silver D;Vinyals O;Senior AW;Kavukcuoglu K;Kohli P;Hassabis D
通讯作者:
Hassabis D
影响因子:
5.2
作者:
Imlay, Leah;Odom, Audrey R
通讯作者:
Odom, Audrey R
影响因子:
14.8
作者:
Kelley LA;Mezulis S;Yates CM;Wass MN;Sternberg MJ
通讯作者:
Sternberg MJ